Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zenouska Ramchunder
Observed names:
Ramchunder, Zenouska,
ZENOUSKA RAMCHUNDER
Institutions:
Queen Mary University of London,
William Harvey Research Institute,
Brunel University of London
Observed institutions:
Queen Mary University of London,
William Harvey Research Institute,
Imperial College London,
Brunel University of London
ORCID:
0009-0008-0194-2311
Observed ORCID:
0009-0008-0194-2311
OpenAlex ID:
A5039356561
Engineered mini-G proteins block the internalization of cognate GPCRs and disrupt downstream intracellular signaling
2024
·
Yusman Manchanda
, Liliane ElEid
, et al.
·
Science Signaling
·
24
Emerging antioxidant therapies in Friedreich’s ataxia
2024
·
Fred Jonathan Edzeamey
, Zenouska Ramchunder
, et al.
·
Frontiers in Pharmacology
·
24
PDF
In vivo and in vitro characterization of GL0034 , a novel long‐acting glucagon‐like peptide ‐1 receptor agonist
2022
·
Ben Jones
, Vinod Burade
, et al.
·
Diabetes Obesity and Metabolism
·
17
PDF
Galleria mellonella as a drug discovery model to study oxidative stress
2025
·
Fred Jonathan Edzeamey
, Zenouska Ramchunder
, et al.
·
Scientific Reports
·
9
PDF
Therapeutic combination of L-ascorbic acid, N-acetylcysteine, and dimethyl fumarate in Friedreich’s ataxia: insights from in vitro models
2025
·
Fred Jonathan Edzeamey
, Zenouska Ramchunder
, et al.
·
Redox Report
·
6
Expression of mini-G proteins specifically halt cognate GPCR trafficking and intracellular signalling
2021
·
Yusman Manchanda
, Zenouska Ramchunder
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
6
PDF
Binding kinetics, bias, receptor internalization and effects on insulin secretion in vitro and in vivo of a novel GLP ‐ 1R / GIPR dual agonist, HISHS ‐2001
2025
·
Yusman Manchanda
, Ben Jones
, et al.
·
Diabetes Obesity and Metabolism
·
5
PDF
87-LB: Binding Kinetics, Bias, Receptor Internalization, and Effects on Insulin Secretion for a Novel GLP1R-GIPR Dual Agonist, HISHS-2001
2021
·
YUSMAN MANCHANDA
, BEN JONES
, et al.
·
Diabetes
·
2
Metabolomics-constrained modelling reveals dominant oxidative metabolism in the Egyptian fruit bat myocardium
2026
·
Anja Karlstaedt
, Fenn Cullen
, et al.
·
PLoS ONE
·
1
PDF
Dual inhibition of SGLT 1 and 2 by sotagliflozin alleviates intracellular sodium overload and improves cardiometabolic remodelling in uraemic cardiomyopathy
2026
·
Megan Young
, Anja Karlstaedt
, et al.
·
Cardiovascular Research
Dual SGLT1/2 inhibition with sotagliflozin improves cardiac function and metabolism in type 2 diabetic mice
2026
·
Megan Young
, Sanushi Dambure
, et al.
·
npj Metabolic Health and Disease
PDF
Dysregulation of sphingolipid-metabolizing enzymes in Friedreich’s ataxia: In vitro and in vivo insights into therapeutic targeting
2026
·
Zenouska Ramchunder
, Ester Kalef-Ezra
, et al.
·
iScience
559 NLRP3 signalling links diabetic metabolic stress to cardiac metabolic remodelling
2026
·
Megan Young
, Hannah Nicholls
, et al.
·
Heart
Metabolomics-constrained modelling reveals dominant oxidative metabolism in the Egyptian fruit bat myocardium
2026
·
Karlstaedt, Anja
, Cullen, Fenn
, et al.
·
Figshare
Deciphering the missing links between Friedreich ataxia and multiple sclerosis for targeted drug development
2026
·
Faith A.A. Kwa
, Sara Anjomani-Virmouni
, et al.
·
Drug Discovery Today
Author response for "Binding kinetics, bias, receptor internalization and effects on insulin secretion in vitro and in vivo of a novel GLP-1R/GIPR dual agonist, HISHS-2001"
2025
·
Manchanda, Yusman
, Jones, Ben
, et al.
·
Publons reviews and discussion
Author response for "In vivo and in vitro characterisation of GL0034, a novel long‐acting GLP‐1 receptor agonist"
2022
·
Ben Jones
, Vinod Burade
, et al.
·
Publons reviews and discussion
Show more works
View as search
Works count:
20
Citation count:
95
H-index:
6
I10-index:
3
Year
Topic
Type